RIVA-CLINDAMYCIN
Identification of Riva-Clindamycin
| No description |
Google image searchProduct monograph
Active ingredient
clindamycin (clindamycin hydrochloride), 300 MG
DIN: 02468484
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: LABORATOIRE RIVA INC.
Date: 13-OCT-2017
ATC:
- J01 — ANTIBACTERIALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J01F — MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS (ATC, ATC/DDD)
- J01FF — Lincosamides (ATC, ATC/DDD)
- J01FF01 — CLINDAMYCIN (ATC/DDD)
Reference brand drug: Dalacin C
Pharmaceutical standard: USP
